Accès ouvert
2026
preprint
OpenAlex
Fabio Dennstädt, Nikola Čihorić, Nicolas Bachmann, I. Filchenko et autres
ABSTRACT Background Large Language Models (LLMs) have demonstrated expert-level performance across many medical domains, suggesting potential utility in clinical practice. However, their reliability in the highly specialized domain of moderate hyperthermia (HT) remains unknown. We therefore evaluated the performance of three modern …
ch, de, nl, us, hu, pl, se
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mattia De Lazzari, Carolina Carrapiço-Seabra, Dietmar Marder, Gerard C. van Rhoon et autres
INTRODUCTION: Hyperthermia efficacy depends on the temperatures achieved in the target area. Therefore, hyperthermia systems must deliver both controlled and conformal heating. This study presents a comprehensive multi-institutional quality assurance (QA) evaluation of deep hyperthermia devices. METHODS: Six European institutions equipped with …
se, nl, ch
(code pays fourni par la source)
Accès ouvert
2024
review
OpenAlex
Adela Ademaj, Sonja M. Stieb, Cihan Gani, Oliver J. Ott et autres
BACKGROUND AND PURPOSE: Combining chemoradiotherapy (CRT) with deep regional hyperthermia (HT) shows promise for enhancing clinical outcomes in selected rectal cancer patients. This study aimed to integrate the evidence and evaluate the efficacy of this combined treatment approach. MATERIALS AND METHODS: A …
ch, de, nl
(code pays fourni par la source)
2024
article
OpenAlex
Adela Ademaj, Oliver J. Ott, Cihani Gani, Olav Mella et autres
2024
article
OpenAlex
Sergio Mingo Barba, Adela Ademaj, Dietmar Marder, Oliver Riesterer et autres
Accès ouvert
2024
article
OpenAlex
Sergio Mingo Barba, Adela Ademaj, Dietmar Marder, Oliver Riesterer et autres
INTRODUCTION: biophysical models that translate deviations in the treatment conditions into clinical outcome variations may be used to study the extent of such processes and their influence on combined hyperthermia plus radiotherapy (HT + RT) treatments under varying conditions. METHODS: An extended …
ch, it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Adela Ademaj, Emsad Puric, Dietmar Marder, Olaf Timm et autres
Purpose: Radiotherapy (RT) in combination with deep regional hyperthermia (HT) after transurethral removal of bladder tumor (TURBT) can be offered to elderly and frail patients with muscle-invasive bladder cancer (MIBC).Methods: In total, 21 patients (mean age 84 years) with unifocal or multifocal …
ch
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Adela Ademaj, Emsad Puric, Olaf Timm, David Kurti et autres
Hyperthermia (HT) in combination with radio(chemo)therapy (RCT) is a well-established cancer treatment strategy. This report analyses the quality of life (QoL), toxicity and survival outcomes in patients with different tumor entities who received HT in combination with RCT. The primary endpoint of …
ch
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Adela Ademaj, Paraskevi Danai Veltsista, Dietmar Marder, Roger A. Hälg et autres
PURPOSE: The combination of hyperthermia (HT) with radio(chemo)therapy or chemotherapy (CT) is an established treatment strategy for specific indications. Its application in routine clinical practice in Europe depends on regulatory and local conditions. We conducted a survey among European clinical centers to …
ch, de, nl, pl, dk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Oliver Riesterer, Adela Ademaj, Emsad Puric, Brigitte Eberle et autres
BACKGROUND: Transurethral resection of bladder tumor (TUR-BT) followed by chemoradiation (CRT) is a valid treatment option for patients with muscle-invasive bladder cancer (MIBC). This study aimed to investigate the efficacy of a tetramodal approach with additional regional hyperthermia (RHT). METHODS: Patients with …
ch, de
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Emanuel Stutz, Emsad Puric, Adela Ademaj, Arnaud Künzi et autres
BACKGROUND: Moderate hyperthermia is a potent and evidence-based radiosensitizer. Several indications are reimbursed for the combination of deep hyperthermia with radiotherapy (dHT+RT). We evaluated the current practice of dHT+RT in Switzerland. METHODS: All indications presented to the national hyperthermia tumor board for …
ch
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Adela Ademaj, Danai P. Veltsista, Pirus Ghadjar, Dietmar Marder et autres
Hyperthermia (HT) is a cancer treatment modality which targets malignant tissues by heating to 40-43 °C. In addition to its direct antitumor effects, HT potently sensitizes the tumor to radiotherapy (RT) and chemotherapy (CT), thereby enabling complete eradication of some tumor entities …
ch, de, nl
(code pays fourni par la source)